SEC Form 4 · accession 0001209191-18-037216
Allena Pharmaceuticals, Inc. · ALNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew A. F. Hack
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 12, 2018 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624658
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.52 | Jun 8, 2018 | A | 20,364 | A | — | Jun 7, 2028 | Common Stock | 20,364 | 20,364 | D |
Explanation of responses
- F1Stock option shall vest in equal annual installments over the three years following the grant date; provided that, if not already vested, such stock option shall vest and become fully exercisable on the date of the third annual meeting of stockholders following the grant date.